What Sanitas does

Instituto Sanitas S.A. is a privately held Chilean pharmaceutical manufacturer founded in 1920, headquartered in Quilicura, Santiago, with a GMP-certified production plant and a workforce of more than 250 employees. The company develops, manufactures, and distributes a portfolio of more than 150 bioequivalent medications across multiple therapeutic categories — primarily cardiology, neuropsychiatry, analgesics/anti-inflammatories, gastroenterology, and dietary supplements — under brands including Vitakron (multivitamin/mineral line), Pylobiotic (probiotic featuring a proprietary Bifidobacterium longum BI-05 strain), Proflora (Bacillus clausii probiotic), Bioinsugen (biosimilar recombinant human insulin), Repelex (repellents), Sanigrip (antiseptic hygiene), and a range of branded cardiovascular, migraine, and insomnia products. Technology assets are conventional pharmaceutical manufacturing (oral solids, softgels, drops) augmented by two modest digital touchpoints: a HOMA Index calculator (a rule-based insulin-resistance estimator) and the Saneduc online continuing-education platform for healthcare professionals. The proprietary strain Bifidobacterium longum BI-05 used in Pylobiotic is the only meaningfully differentiated technical asset described in the source material.

Sanitas monetizes primarily through wholesale and retail sale of pharmaceutical products — both prescription and OTC — in the Chilean domestic market. The go-to-market is a hybrid channel model: products are sold through the three major Chilean pharmacy chains (Salcobrand, Cruz Verde, Farmacias Ahumada) and independent pharmacies, supplied directly to healthcare institutions and the national health system via a field-sales motion, and increasingly retailed through the company's own e-commerce storefront (sanitassalud.cl). Healthcare professionals are engaged separately as a prescribing/influencing segment through technical documentation, the Saneduc education platform, and tools such as the HOMA calculator. Pricing is not publicly disclosed; the company competes on bioequivalence certification (ISP), affordability, and a broad SKU base rather than on premium pricing. There is no evidence of international distribution, and all disclosed operations, certifications, and distribution relationships are Chile-anchored.

Name

Sanitas

Legal name

Instituto Sanitas S.A.

Website

https://sanitas.cl

Company type

Private

Founded year

1920

Operating status

Operating

Headcount range

251–500 employees

Short description

Instituto Sanitas S.A. is a Chilean pharmaceutical manufacturer founded in 1920 that produces and distributes 150+ bioequivalent medications across cardiology, neuropsychiatry, and supplements through pharmacy chains, institutional supply, and direct e-commerce in Chile.

Ownership category

akta.pro rank

Headquarters

HQ city

Santiago

HQ country

Chile

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from manufacturing and selling pharmaceutical products including prescription medications, over-the-counter drugs, and dietary supplements through pharmacy distribution channels and direct sales
2. Bioequivalent Generic Medications: Sale of ISP-certified bioequivalent medications across multiple therapeutic categories including cardiology, neuropsychiatry, analgesics, and other specialties

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Instituto Sanitas S.A. manufactures and sells a portfolio of more than 150 pharmaceutical products, including ISP-certified bioequivalent prescription medications, over-the-counter drugs, and dietary supplements, spanning cardiology, neuropsychiatry, analgesics, anti-inflammatory, gastrointestinal, and nutritional categories. Products are produced at a GMP-certified plant in Quilicura, Santiago, and distributed across Chile through major pharmacy chains, healthcare institutions, and the company's own e-commerce storefront.

Product overview

Instituto Sanitas S.A. is a Chilean pharmaceutical company with over 100 years of experience, offering more than 150 medications across various specialties including Cardiology, Neuropsychiatry, Analgesics, and Anti-inflammatory categories. The company operates a GMP-certified manufacturing plant and distributes through pharmacy chains across Chile. The product portfolio includes branded pharmaceutical products (Pylobiotic probiotic, Vitakron vitamin/mineral supplements, Flectane NSAID, Enterol S probiotic, various cardiovascular and CNS medications), supported by digital tools for healthcare professionals (HOMA Index Calculator) and the Saneduc educational platform. Products are distributed through major Chilean pharmacy chains including Farmacias Ahumada, Salcobrand, Cruz Verde, and others.

Differentiator

Problem solved

Functional benefit

Brands

• Sanigrip: Product brand for grip/flu medications
• Vitakron
• Repelex
• Proflora

Products and services

• Pylobiotic Probiotic supplement containing Bifidobacterium longum strain BL-05, indicated for restoring intestinal microbiota balance and reducing symptoms associated with Irritable Bowel Syndrome. Sold to patients through pharmacy retail and e-commerce channels in Chile.
• Vitakron 3 Multivitamin multimineral supplement designed to provide essential vitamins and minerals for general health maintenance. Sold to patients through pharmacy retail and e-commerce channels in Chile.
• Vitakron A-Z Multivitamin multimineral supplement containing 13 vitamins and 11 minerals in soft capsule form for comprehensive nutritional support. Sold to patients through pharmacy retail and e-commerce channels in Chile.
• Vitakron Hombre Multivitamin multimineral supplement formulated with 13 vitamins and 11 minerals tailored for male nutritional needs. Sold to patients through pharmacy retail and e-commerce channels in Chile.
• Vitakron Mujer Multivitamin multimineral supplement formulated with 13 vitamins and 11 minerals tailored for female nutritional needs. Sold to patients through pharmacy retail and e-commerce channels in Chile.
• Vitakron Silver Multivitamin multimineral supplement formulated with 13 vitamins and 11 minerals for senior adults. Sold to patients through pharmacy retail and e-commerce channels in Chile.
• Deline / Deline Gotas / Deline Vitamina D3 Vitamin D3 supplement available in liquid drops and soft capsule forms for calcium absorption and bone health support. Sold to patients through pharmacy retail and e-commerce channels in Chile.
• Flectane 500/20 mg Combined NSAID (Naproxeno) and proton pump inhibitor (Esomeprazol) medication for treating osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis in patients at risk of developing gastric ulcers. Prescribed and dispensed to patients in Chile.
• Enterol S 250 mg Probiotic medication containing Saccharomyces boulardii yeast for treatment of non-specific diarrhea and as complement to rehydration therapy. Dispensed to patients in Chile.
• Lactobasan Lactase enzyme supplement (9000 FCC) that facilitates proper digestion of lactose to avoid gastrointestinal symptoms when consuming dairy products. Sold to patients through pharmacy retail and e-commerce channels in Chile.
• Nospasmin Antispasmodic medication containing Pargeverina Clorhidrato for treatment of intestinal, biliary, renal, and female genital spasms. Dispensed to patients in Chile.
• Cefalmin Antimigraine medication containing Ergotamina, Metamizol, Clorfenamina, and Cafeína for treatment of vascular headache (migraine) and histamine headache. Dispensed to patients in Chile.
• Manol / Manol Plus ODT Analgesic medication containing Tramadol Clorhidrato for moderate to severe pain relief, available in drops and oral dispersible tablet forms. Dispensed to patients in Chile.
• Cobefen Combined antihistamine and corticosteroid medication (Betametasona/Dexclorfeniramina) for treatment of acute or chronic allergic manifestations, particularly respiratory, dermatological, and ocular. Dispensed to patients in Chile.
• Bioinsugen (30/70, N, R) Biosimilar recombinant human insulin products including biphasic (30/70), N (isophane), and R (regular) formulations for diabetes treatment. Dispensed to patients in Chile.
• Corasol / Corasol-D Cardiovascular medication available in 40mg and 80mg doses for hypertension treatment. Dispensed to patients in Chile.
• Cardiolen Calcium channel blocker containing Verapamilo in 80mg and 120mg capsules for cardiovascular conditions. Dispensed to patients in Chile.
• Brontal (Adulto/Infantil) Combined mucolytic and antitussive medication (Bromhexine/Clofedianol) for treatment of respiratory conditions with mucus, available in adult and pediatric formulations. Dispensed to patients in Chile.
• Sanigrip Hand soap with antiseptic properties for disinfection and hygiene purposes. Sold to patients through pharmacy retail and e-commerce channels in Chile.
• Repelex (Crema, Forte, Fresh, Kids, Loción Spray, NF, SUN) Family of insect repellent products including cream, aerosol spray, fresh, children's formulations, and sun protection variants. Sold to patients through pharmacy retail and e-commerce channels in Chile.
• Somnipron Sleep aid medication containing Zolpidem 10mg for treatment of insomnia. Dispensed to patients in Chile.
• Proflora Probiotic supplement containing Bacillus clausii spores for intestinal flora restoration. Sold to patients through pharmacy retail and e-commerce channels in Chile.

Quantifiable outcome

• Over 150 bioequivalent medications available across therapeutic categories
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Laboratorio Chile (Eurofarma): One of Chile's largest domestic pharmaceutical manufacturers, now part of Brazil's Eurofarma group. Directly comparable to Sanitas as a Chilean-based manufacturer of generic and bioequivalent medications distributed through national pharmacy chains, targeting the same cardiovascular, CNS, and OTC therapeutic areas.
• Laboratorio Saval: Chilean pharmaceutical company with a broad portfolio of generic and branded prescription products, also distributed through major Chilean pharmacy chains. Closely matches Sanitas in therapeutic breadth, domestic manufacturing footprint, and reliance on bioequivalent/prescription generics.
• Knop Laboratorios: Chilean pharmaceutical laboratory with a long history in the local market, producing generics, OTC, and natural health products. Comparable to Sanitas in scale, domestic manufacturing orientation, and therapeutic coverage across chronic and acute categories.
• Pharma Investi de Chile: Chilean pharmaceutical manufacturer focused on generic and prescription medications with national distribution. Comparable to Sanitas as a mid-sized Chilean generic pharma player leveraging ISP-certified bioequivalent products across similar therapeutic categories.

Broad incumbents

• Bayer Chile: Local subsidiary of Bayer AG distributing branded pharmaceuticals, OTC, and consumer health products in Chile. Competes with Sanitas across several OTC and prescription categories but as part of a much broader multinational portfolio rather than a domestic generics specialist.
• Sanofi Chile: Chilean operations of global pharma major Sanofi, with a broad portfolio spanning cardiovascular, CNS, vaccines, and consumer health. Overlaps with Sanitas in cardiovascular and neuropsychiatry but competes from a global branded-pharma base rather than domestic generics.
• Eurofarma Laboratórios: Brazilian multinational pharmaceutical company with significant LatAm reach, including ownership of Laboratorio Chile. Competes with Sanitas through its Chilean subsidiary and through cross-border generics that reach Chilean pharmacy chains.

Regional players

• Laboratorios Maver: Mexican pharmaceutical company with growing Latin American footprint in generics and OTC products. Comparable to Sanitas in therapeutic breadth and bioequivalent focus, though primarily operates from Mexico rather than competing directly head-to-head in Chile today.
• Genomma Lab Internacional: Mexican OTC and personal care pharmaceutical company with broad Latin American distribution. Comparable to Sanitas in OTC/supplement category positioning (similar to Vitakron/Repelex) and channel strategy through pharmacy chains, though headquartered in Mexico.
• Laboratorios Roemmers: Argentine pharmaceutical group with a large prescription and OTC portfolio distributed across multiple South American markets including Chile. Comparable to Sanitas in therapeutic breadth (cardio, CNS, analgesics) and bioequivalent presence, though anchored in Argentina.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/sanitas-s.a.
• Facebookfacebook.com/InstitutoSanitasChile

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sanitas